0

Poloxamer solid

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP9003116-C
CAS9003-11-6
Structure
MDL NumberMFCD00082049
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size1G
1

Development and in Vitro Evaluation of Solid Dispersions as Strategy to Improve Albendazole Biopharmaceutical Behavior

Analía Simonazzi, Alicia Graciela Cid, Alejandro Javier Paredes, Laureano Schofs, Elio Emilio Gonzo, Santiago Daniel Palma, José María Bermúdez

Ther Deliv. 2018 Sep;9(9):623-638.

PMID: 30189808

1

Dissolution Rate Enhancement and Physicochemical Characterization of Carbamazepine-Poloxamer Solid Dispersions

Djordje P Medarević, Kyriakos Kachrimanis, Miodrag Mitrić, Jelena Djuriš, Zorica Djurić, Svetlana Ibrić

Pharm Dev Technol. 2016;21(3):268-76.

PMID: 25582577

1

Physicochemical Characterizations of Piroxicam-Poloxamer Solid Dispersion

S C Shin, C W Cho

Pharm Dev Technol. 1997 Nov;2(4):403-7.

PMID: 9552469

1

Process Optimization and Characterization of Poloxamer Solid Dispersions of a Poorly Water-Soluble Drug

Tejal J Shah, Avani F Amin, Jolly R Parikh, Rajesh H Parikh

AAPS PharmSciTech. 2007 Apr 13;8(2):Article 29.

PMID: 17622107

1

Stochiometrically Governed Molecular Interactions in Drug: Poloxamer Solid Dispersions

W Ali, A C Williams, C F Rawlinson

Int J Pharm. 2010 May 31;391(1-2):162-8.

PMID: 20214957

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode